and biological systems included in the AL index differed widely across studies, as did the 23 method of calculating the AL index. All studies included at least one cardiovascular-and 24 metabolic-related biomarker in AL indices, while only half of studies included at least one hy-25 pothalamic-pituitary-adrenal (HPA) axis biomarker and approximately one third an immune 26 response-related biomarker. All but three studies found evidence of an association between 27 lower SEP and higher AL. 28 
29
Conclusions: Many studies lacked fidelity to the original concept of AL in which stress was 30 considered central. The considerable variation in biomarkers used makes studies in this re-31 view difficult to compare. A more critical approach should be taken in the calculation of AL 32 indices in particular to how far it captures the biological effects of psychosocial stress that 33 may underlie socioeconomic differences in health. 34 
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Introduction 36
The social underpinnings of disease have been long acknowledged and an extensive body 37 of literature has linked lower socioeconomic position (SEP) with adverse health outcomes. [1] [2] [3] 
38
The underlying mechanism for some diseases is better understood than others. For 39 example, it is well established that in high income countries those of a lower SEP are more 40 likely to smoke, be hypertensive and have increased cholesterol, which in turn results in an 41 increased risk of cardiovascular disease (CVD) events. [4] [5] [6] [7] However, the extent to which 42 stress plays a role in the specific mechanisms through which social factors influence disease 43 has remained elusive. Two key areas of research have emerged: one focused on how stress 44 is related to behavioral mechanisms of disease and the other on the biological mechanisms 45 responsible for translating stress into disease. [8] [9] [10] [11] The latter has emphasized understanding 46 how the body internalizes an external stressor on a physiological level and how well a 47 person can adapt to changes in his or her environment. Allostasis is a concept describing 48 the normal process of how the human body adapts in response to a given stimulus. Allostatic load (AL) is defined as the physiological "wear and tear" a person experiences 50 across his or her life, for instance chronically elevated blood pressure resulting from a 51 lifetime of occupational strain. 13 
52
According to the original AL framework, stress hormones controlled by the hypothalamic-53 pituitary-adrenal (HPA) axis (e.g. cortisol, epinephrine, and norepinephrine) are the "primary 54 mediators" of AL, which in turn mediate "secondary effectors" such as blood pressure, lipid 55 metabolism, and inflammation. 13, 14 Poor health conditions resulting from extreme values of 56 primary mediators and secondary effectors are "tertiary outcomes" (e.g. coronary heart 57 disease, decreased physical capacity, obesity or severe cognitive decline). [15] [16] [17] In the first 58 study to calculate an AL index, measurements of 10 biomarkers were combined from three 59 biological domains (cardiovascular and metabolic systems, and HPA axis).
18 For clarity, in 60 this paper AL index refers to the quantifiable variable, while allostatic load refers to the 61 conceptual framework devised by McEwen & Stellar. 13 M A N U S C R I P T quantified the heterogeneity in AL indices. Previous reviews of AL, health disparities and 73 outcomes have been performed, but none had a methodological focus, although some 74 attention has been given to comparing different methods for how levels of constituent 75 biomarkers should be arithmetically combined into a single index. 15, [20] [21] [22] [23] [24] 
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In this systematic review we have aimed to provide a comprehensive overview and discussion 77 of the biomarker content and methods used to calculate AL in studies that have looked at its 78 association with SEP. A secondary aim was to describe the associations of AL with SEP. 79
Methods
80
Search Strategy & Data Extraction
81
The scope of this review was limited to the biological internalization of SEP and the effects of 82 this stressor on AL, highlighting AL as a mechanism on the causal pathway between SEP 83 and health outcomes (Fig 1) .
The literature review was restricted to peer-reviewed publications of human population 86 studies that calculated an AL index and analysed the association between SEP as the main 87 exposure and AL as the main outcome. Reviews, protocols, conference abstracts, and 88 theoretical discussions were excluded. We sought to find all studies including the phrase 89 "allostatic load", "biomarker", and SEP. Specific search terms can be found in Appendix A. 90 Five electronic databases were searched (Embase, Global Health, MEDLINE, and 91 PsychINFO) to identify articles published up to July 7 th 2017, with no language restrictions. 92 Additionally, previous reviews of AL and social factors were cross-referenced to check the 93 sensitivity of the search strategy. [22] [23] [24] The preferred reporting items for systematic reviews 94 and meta-analyses (PRISMA) guidelines were followed with a focus on methodologies used 95 to operationalise AL. 25 
96
Analyses
97
We reviewed the biomarkers included in AL indices according to biological system, as 98 defined by the study, and then looked at the frequency of papers in which each biomarker 99 was included. Biomarkers that were measured differently were included as separate 100 biomarkers; for instance, fasting glucose measures and non-fasting glucose measures were 101 categorised as two separate biomarkers. A sensitivity analysis was also performed, where 102 closely related biomarkers with minor differences were collapsed into one biomarker. 103 We quantified the extent to which papers used the same set of biomarkers in their AL index 104 using a pair-wise approach in which the biomarker set of each study was compared to that of 105 every other study. For every pair-wise comparison we counted the number of biomarkers 106 that they used in common. This could vary between zero and total number of discrete 107 biomarkers observed across all included papers. In addition we identified every uniqueM A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 6 biomarker combination observed, and counted the number of studies using any unique 109 combination. 110 We analysed the data using MS Excel and analysed using Stata 14.1. 111 
Results
112
Findings from the literature search 113 The search strategy outlined above identified 282 papers; four additional papers were 114 included from cross-referencing previous systematic reviews resulting in 287 articles 115 screened (Fig 2) . Thirty-one full text articles were reviewed after duplicate removal and title 116 and abstract screening. Of these, five articles were excluded due to not reporting a direct 117 measure of the association between AL and SEP, leaving a total of 26 articles. Of these 26, 118 four analysed the National Health and Nutrition Examination Survey, three that used the 119 Midlife in the US survey, and two that used the West of Scotland Twenty-07 study. 120
FIGURE 2 HERE
121
The majority of studies were cross-sectional, used US-based population datasets, had a 122 sample size between 1000 and 10,000 observations ( individual was determined to be "high risk". The majority of studies (73%) used quartile-137 based cutoffs for individual biomarkers, and the scores for each biomarkers would then be 138 summed (with each biomarker equally weighted). Cortisol was the only biomarker that had 139 different cutoffs from the other biomarkers. For example, 3 studies used quartile cutoffs for 140 all biomarkers except cortisol, where the lowest and highest octiles were considered high 141 risk, based on previous studies associating extremely low and extremely high levels of 142 cortisol with adverse health outcomes.
26-28
143
Rather than summing individual biomarkers, four studies summed the proportion of high risk 144 markers by biological system. [29] [30] [31] [32] For example, if a person was above the high-risk cutoff for 145 two out of four cardiovascular biomarkers, they would receive a score of 0.5 for this system. 146 This approach was used in studies analysing the Midlife in the US study where over 20 147 biomarkers were combined from five or more biological systems to calculate an AL index. 148 Most studies analysed AL index as a continuous outcome (e.g. a score ranging from 0-10), 149 while others dichotomized the AL index into "high" (e.g. above three) and "low" (e.g. below or 150 at three). Four studies included the same nine biomarkers from the immune response, 151 cardiovascular and metabolic systems with no HPA axis biomarker. [33] [34] [35] [36] Two studies included 152 the same 24 biomarkers from the immune response, HPA axis, and cardiovascular, 153 metabolic, respiratory and parasympathetic nervous systems. 31, 32 All remaining 20 studies 154 used different sets of biomarkers to calculate AL.
Analysis of shared biomarkers
156
To understand how biomarkers were shared between studies, each study (n=26) was paired 157 with all other studies for a potential of 325 pair-wise combinations. Table 3 shows the total  158 pairs of studies, according to the number of biomarkers the study pairs have in common. 159 Also shown are how many pairs share distinct groups of biomarkers, referred to as unique 160 combinations. For example, the last row of the table shows that 16 study pairs shared only 161 one common biomarker, among which there were five unique biomarker combinations (in 162 this case, five unique biomarkers). It was most common for two studies to share five 163 biomarkers, with 55 pairs of studies (17% of all pairs) sharing exactly five biomarkers. 164 Twenty-four of these pairs (44%) were unique combinations of biomarkers. Only five pairs of 165 studies had 10 biomarkers in common, four of which (80%) were unique combinations. 166 Substantial heterogeneity was observed across AL indices when comparing studies to each 168 other. Across all the possible combinations of biomarkers shared by two studies, the most 169 commonly shared group of biomarkers was waist to hip ratio, systolic blood pressure, 170 diastolic blood pressure and high density lipoprotein cholesterol, which appeared in 11 pairs 171 of studies. The other biomarkers used in these AL indices hardly overlapped and were often 172 categorised in different biological systems. For example, one study appeared in nine of the 173 11 pairs and additionally included biomarkers from the metabolic system and the HPA axis. Another study appeared twice and included metabolic system-related, immune response and 175 HPA axis markers. 49 A sensitivity analysis in which closely related but distinct biomarkers 176 (e.g. fasting and non-fasting glucose) were collapsed into fewer broader classes (e.g. 177 glucose) did not change our findings (see Supplementary Table S4) . Instead, a qualitative description of the strength of association was assigned based the 186 magnitude of effect measures. However, in almost all studies lower SEP groups had higher 187 AL indices (Table 4) , while three studies found evidence of effect modification. One study 188 found the association between AL and SEP differed by ethnicity while two others found the 189 association differed by gender (Table 4) 
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Lastly, all but three studies found a negative association between AL and SEP, such that 203 SEP decreased as AL increased. 204 Whether or not a biomarker was included in AL indices appeared to be dependent on which 205 biomarkers were collected. Papers analysing the MIDUS study, for example, all included 206 HPA-axis related biomarkers whereas none of the studies analysing the NHANES included 207 such markers. The MIDUS study was designed to explore the psychosocial factors affecting 208 health outcomes in ageing Americans and contained an extensive biomarker profile whereas 209 the NHANES was focused on nutritional status and disease. Not all studies are equally well 210 suited for calculating an AL index, however, many studies appropriated the term AL 211 regardless of how closely their index matched with the original conceptual framework. 212 The substantial inconsistency in biomarkers used to operationalise AL and the lack of fidelity 213 to its original conception as an index that captures the biological response to psychosocial 214 stress is striking. This suggests that the empirical literature on AL is intrinsically flawed and 215 without a strong conceptual basis. Cardiovascular-and metabolic-related markers were not 216 only ubiquitous in AL definitions, but were also overrepresented in many studies relative to 217 other biological systems. It is well known that cardiovascular-and metabolic-related risk 218 factors for CVD increase for those of a lower SEP, and these biomarkers are also more 219 closely related to health behaviors (e.g. smoking and an increase in blood pressure). [39] [40] [41] [42] [43] By 220 contrast, HPA axis biomarkers were absent from nearly half of studies, which contradicts 221 McEwen & Stellar's initial conceptual framework emphasizing the importance of HPA axis 222 biomarkers as primary mediators. In fact, AL is defined as the result of the "heightened 223 neural or neuroendocrine response resulting from repeated or chronic environmental 224 challenge". 13 Other biological systems, such as kidney/liver function, have been added into 225 AL indices, despite not being included in this original conceptualization. This divergence 226 makes it difficult to know what is being measured by AL, let alone interpret findings thatM A N U S C R I P T
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Despite the considerable inconsistency in AL operationalisation, the vast majority of articles 229 reviewed found a negative association between SEP and AL. It is not expected that a 230 reworking of the operationalisation of AL would dramatically affect these associations. 231 Rather, the lack of coherence makes it difficult to compare findings from different studies (for 232 example, in comparing the strength of association between AL and different SEP indicators), 233 and therefore hinders a better understanding of the biological mechanisms underlying poorer 234 health amongst those of a lower SEP. 235 Efforts to translate the concept of AL into a quantifiable variable have been widespread, 267 however, it is crucial to consolidate this information, as we have done here, to improve AL 268 studies. By excluding the HPA axis, these studies do not contribute to our current 269 understanding of AL. 270 
Strengths & limitations
Concluding remarks
271
In conclusion, this review identified substantial methodological inconsistencies in calculating 272 AL indices and a clear divergence from the original conceptual framework in the literature on 273 AL and SEP. In the nearly 20 years since AL was first operationalised, the literature has 274 become increasingly heterogeneous in the way composite AL indices are calculated. M A N U S C R I P T 
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